GLP-1 Side Effects: How Long They Last and How to Manage Them
GLP-1 side effects management — what it is, who is a candidate, and how we approach it clinically. A patient guide from Travis Woodley, NP.
6/9/2026
Browse the complete long-form patient education library with transparent sources and clear pathways back into care.
GLP-1 side effects management — what it is, who is a candidate, and how we approach it clinically. A patient guide from Travis Woodley, NP.
6/9/2026
A clinical guide to nutrition during semaglutide or tirzepatide therapy — protein targets, muscle preservation, managing reduced appetite, and building patterns that last beyond the medication period.
5/10/2026
An updated clinical comparison of tirzepatide and semaglutide for 2026 — incorporating the latest trial data, real-world experience, and guidance on which is more appropriate for different clinical situations.
5/9/2026
A clinical guide to insulin resistance — what it is, how to identify it, what drives it, and why addressing it is central to any meaningful approach to mid-life weight and metabolic health.
5/8/2026
Glucose is improving. Weight is moving. Appetite is down on a GLP-1. So why does the patient still look inflamed and feel metabolically stuck? Travis Woodley on why uric acid is the marker that often answers the question once the obvious wins start showing up.
5/4/2026
A clinical guide to medical weight loss for patients in Warner Robins, Bonaire, Perry, and Houston County. What distinguishes a clinical program, how the process works, and what to expect at Revitalize.
5/1/2026
A guide for patients in Columbus, Phenix City, and Fort Benning and the surrounding military community evaluating medical weight loss programs. What distinguishes clinical programs from commercial diets, and what to expect at Revitalize.
4/22/2026
The calories-in-calories-out framework explains a lot — but it fails to account for the hormonal realities of mid-life metabolism. Here is what is actually happening.
3/22/2026
Weight regain after stopping semaglutide or tirzepatide is common and significant. The clinical approach to the off-ramp determines whether the treatment produces lasting change or a temporary result.
3/1/2026
Most patients on GLP-1 medications experience a plateau at some point. Understanding why it happens — and what the clinical options are — determines what comes next.
2/22/2026
Vitamin A, D3, and K2 are not “nice add-ons” to a supplement stack—they are the traffic controllers for calcium, thyroid conversion, and hormone receptors.
1/24/2026
Creatine: The Overlooked Metabolic Workhorse for Muscle, Brain, and Fertility
1/24/2026
A clinician's explanation of the GLP-1 mechanism, what semaglutide actually does in the body, and what patients should understand before starting.
4/15/2025
Why most diet programs fail at mid-life, and what a metabolic approach to weight loss actually addresses that a diet plan cannot.
4/1/2025